Onward
Onward is a medical technology company focused on developing therapies aimed at enabling functional recovery for individuals with spinal cord injuries. The company is creating an Implantable Neuro-stimulation System (INS) that features real-time motion feedback and utilizes training tools for rehabilitation. Onward has developed two platforms for neurostimulation: ARCIM, an implantable system, and ARCEX, a non-invasive transcutaneous system. To establish its customer base, Onward has targeted the United States and four European markets, namely Germany, France, the United Kingdom, and the Netherlands.
1 past transactions
NeuroRecovery Technologies
Acquisition in 2019
NeuroRecovery Technologies, Inc. is a medical device company that specializes in the development of therapeutic systems aimed at restoring function and movement in individuals suffering from paralysis. Founded in 2013 and based in San Juan Capistrano, California, the company focuses on creating both external and implantable spinal cord neuromodulation systems. Its technology is the result of collaborative research involving prestigious institutions such as the University of California, Los Angeles, the California Institute of Technology, and the University of Louisville. NeuroRecovery Technologies has positioned itself at the forefront of recovery and rehabilitation innovations for patients with paralysis, particularly those who have sustained spinal cord injuries. In October 2019, the company was acquired by G-Therapeutics B.V.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.